Krzysztof Glowacki has been given a four-year ban after failing his drug test, which proved his use of an anabolic steroid. UK Anti-Doping announced the decision this week, effectively preventing the former WBO junior-heavyweight title holder from joining any sport within the said period. (via Reuters)
Glowacki failed the test after his bout with Richard Riakporhe in Manchester a year ago. Prior to his suspension, the fighter denied using any prohibited substance, which led to his provisional suspension in April 2023. However, after his urine came back with traces of Boldenone, which is included in the World Anti-Doping Agency (WADA) 2023 Prohibited List, and an independent National-Anti-Doping Panel (NADP) addressed his case, Glowacki was given the ban.
The news is a huge punch for Glowacki, who made a mark in the boxing world. The fighter held the WBO junior heavyweight title two times, with the first being from 2015 to 2016 and the second time in 2019. He also succeeded in 32 of all the 36 professional fights he had. Aside from that, the fighter started exploring the MMA industry after making his debut at the KSW 83: Colosseum 2 event in June 2023. In the event, the fighter made a phenomenal KO win against his opponent.
However, with the recent decision for his suspension, Glowacki would have to halt his sports career for four years, effectively marking his absence in the industry until 2027.
